2.10
Precedente Chiudi:
$2.10
Aprire:
$2.09
Volume 24 ore:
21,419
Relative Volume:
0.08
Capitalizzazione di mercato:
$36.38M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.96%
1M Prestazione:
+1.45%
6M Prestazione:
-20.15%
1 anno Prestazione:
-41.99%
Mural Oncology Plc Stock (MURA) Company Profile
Nome
Mural Oncology Plc
Settore
Industria
Telefono
353 1 905 8020
Indirizzo
10 EARLSFORT TERRACE, DUBLIN 2
Confronta MURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MURA
Mural Oncology Plc
|
2.10 | 36.38M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.22 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
674.55 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.95 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.64 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.69 | 40.93B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-04-04 | Iniziato | Morgan Stanley | Overweight |
Mural Oncology Plc Borsa (MURA) Ultime notizie
What analysts say about Mural Oncology plc stockSector Rotation Strategies & Get The Analyst Consensus With One Click - earlytimes.in
Is it too late to sell Mural Oncology plc2025 Risk Factors & Free Long-Term Investment Growth Plans - newser.com
How Mural Oncology plc stock performs during Fed tightening cyclesEarnings Growth Report & Trade Opportunity Analysis Reports - newser.com
Is Mural Oncology plc a candidate for recovery playTrade Volume Report & Low Risk High Reward Ideas - newser.com
Mural oncology CMO Goodman sells $10k in shares By Investing.com - Investing.com Nigeria
Mural Oncology CFO Cutler sells $14939 in shares By Investing.com - Investing.com Nigeria
Mural oncology CMO Goodman sells $10k in shares - Investing.com India
Mural Oncology CFO Cutler sells $14939 in shares - Investing.com
Is Mural Oncology plc stock ready for a breakout2025 Price Targets & Smart Allocation Stock Reports - newser.com
Citadel Group discloses 1.28% stake in Mural Oncology By Investing.com - Investing.com South Africa
Citadel Group discloses 1.28% stake in Mural Oncology - Investing.com
What candlestick patterns are forming on Mural Oncology plcShare Buyback & Safe Entry Point Alerts - newser.com
Mural Oncology plc SEC 10-Q Report - TradingView
Why Mural Oncology plc stock is favored by pension fundsMarket Activity Recap & Free Community Consensus Stock Picks - newser.com
Published on: 2025-11-06 04:45:43 - newser.com
Combining price and volume data for Mural Oncology plcWatch List & Stepwise Entry and Exit Trade Signals - newser.com
Can trapped investors hope for a rebound in Mural Oncology plc2025 AllTime Highs & Safe Capital Growth Tips - newser.com
Is Mural Oncology plc stock attractive for growth ETFsEntry Point & Risk Managed Investment Signals - newser.com
Chart overlay techniques for tracking Mural Oncology plc2025 Historical Comparison & Reliable Intraday Trade Plans - newser.com
BlackRock discloses 1.64% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.11% stake in Mural Oncology By Investing.com - Investing.com Australia
Exit strategy if you’re trapped in Mural Oncology plcEarnings Risk Report & Community Driven Trade Alerts - newser.com
BlackRock discloses 1.64% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.11% stake in Mural Oncology - Investing.com
Mural Oncology shareholders approve acquisition by XRA 5 Corp. - MSN
Will Mural Oncology plc stock maintain dividend yieldBreakout Watch & Precise Swing Trade Entry Alerts - newser.com
Mural Oncology Plc Azioni (MURA) Dati Finanziari
Non sono disponibili dati finanziari per Mural Oncology Plc (MURA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Mural Oncology Plc Azioni (MURA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Goodman Vicki L | Chief Medical Officer |
Nov 10 '25 |
Sale |
2.08 |
5,036 |
10,475 |
84,727 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):